Form D — Antigenix Therapeutics, Inc.
0002073993-25-000001 · filed Oct 24, 2025
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $8,363,695
- Total sold
- $3,363,695
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Antigenix Therapeutics, Inc.
- CIK
- 2073993
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 300 CARNEGIE CENTER, SUITE 150
PRINCETON, NJ 08540 - Phone
- (317) 552-5240
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Whitfield · Executive OfficerNew Jersey, NJ Find on LinkedIn ↗
-
Shaun Hawkins · DirectorNew Jersey, NJ Find on LinkedIn ↗
-
Kwesi Frimpong-Boateng · DirectorNew Jersey, NJ Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗